Welcome to our dedicated page for Alpine Immune Sc news (Ticker: ALPN), a resource for investors and traders seeking the latest updates and insights on Alpine Immune Sc stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Alpine Immune Sc's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Alpine Immune Sc's position in the market.
Alpine Immune Sciences (NASDAQ:ALPN) reported its Q3 2020 results, highlighting a revenue increase to $1.9 million, up from $0.3 million in Q3 2019. The company successfully raised $60 million in a private placement, enhancing its cash position to $141.3 million. Key developments include preparations for a Phase 2 study of ALPN-101 for systemic lupus erythematosus and ongoing enrollment in a Phase 1 study for ALPN-202. Despite a net loss of $6.1 million in Q3 2020, sufficient funds are projected to support operations into 2024.
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) will announce its third quarter 2020 financial results on November 12, 2020, after market closure. The company will also host a conference call and live webcast at 4:30 p.m. ET to discuss these results along with a corporate update. For those wishing to join the call, the domestic phone number is (800) 816-3005 and the international number is (857) 770-0069. A replay will be available on the company’s website for 90 days following the live event.